Michels Family Financial’s AbbVie ABBV Stock Holding History

Michels Family Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$623K	Hold	2,477	–	–	0.4%	78
2026 Q1	$539K	Hold	2,477	–	–	0.39%	82
2025 Q4	$566K	Buy	2,477 +52	+2%	+$11.8K	0.42%	83
2025 Q3	$561K	Sell	2,425 -14	-0.6%	-$2.85K	0.44%	73
2025 Q2	$453K	Buy	2,439 +22	+0.9%	+$4.09K	0.39%	85
2025 Q1	$506K	Buy	2,417 +53	+2%	+$10.3K	0.46%	76
2024 Q4	$420K	Buy	+2,364	New	+$435K	0.38%	87

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Michels Family Financial's ABBV Position: Q2 2026 in Review

Michels Family Financial held its AbbVie (ABBV) position steady in Q2 2026 at 2,477 shares worth $623K. The position accounts for 0.4% of the portfolio, ranked #78.

Michels Family Financial first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,238 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Michels Family Financial held 2,477 shares of AbbVie worth $623K as of Q2 2026.
Michels Family Financial left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.4% of Michels Family Financial's portfolio in Q2 2026, its #78 holding.
Michels Family Financial first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,238 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Michels Family Financial's 13F filing for Q2 2026, filed 14 Aug 2026.